Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ciphergen Biosystems(CIPH): -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (11)	12/7/2001 11:00:48 AM
From: tuck	Respond to of 510

One anecdotal way of guesstimating the market acceptance of various chips is to look for their use in published research. CIPH's chips (one of their people, at least) are apparently being used in studying the relationship of amyloid precursor protein to master neuron cell death and plaque formation in Alzheimer's patients. Message 16760047 I see work with AFFX's GeneChips all over, for instance. Less involving LMNX, and nada about ACLA and ILMN, since they haven't launched yet. CIPH seems to be getting some traction in the protein chip biz, and first mover advantage seems to be theirs. Other perspectives welcome. Cheers, Tuck